HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Estee Lauder Q2 Makeup Sales Up 11% Driven By MAC, Bobbi Brown, Stila

This article was originally published in The Rose Sheet

Executive Summary

Estee Lauder makeup sales increased 11% to $476.8 mil. on a reported basis in the fiscal second quarter (ended Dec. 31) driven by MAC, Bobbi Brown and Stila, which each grew by double digits, CEO Fred Langhammer reported to analysts Jan. 30

You may also be interested in...



Estee Lauder Darphin Buy To Extend Firm’s International Reach

Estee Lauder has signed an agreement to acquire the Paris skin care manufacturer Darphin, according to the company

Estee Lauder Places Bet On Spade With Premier Beauty Launch

Kate Spade's premier fragrance and bath and body care offerings slated to hit counters in May will be backed by 10 mil. samples including scented postcards announcing the launch of Kate Spade Beauty, Estee Lauder VP-Marketing Worldwide Deborah Clark said

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010932

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel